Digest
| The first 150 words of the full text of this article appear below. |
It has long been suspected that long term gastric acid suppression might be associated with adenocarcinoma of the oesophagus and stomach. This is the first prospective study examining this question. The study is large, including 4 340 207 patient years follow-up from the British General Practitioners research database. Patients given acid suppressing drugs for reflux symptoms had a fivefold increased risk of oesophageal adenocarcinoma, whereas patients treated for gastroduodenal symptoms were not at increased risk. Similarly, patients given acid suppressing drugs for gastric and duodenal ulceration had a fourfold increased risk of gastric non-cardia adenocarcinoma, whereas those treated for oesophageal or other gastroduodenal symptoms were not. Together, these data suggest that the increased risk is derived from the underlying disease and not the acid suppressing drugs themselves.
See p 1538
|
View this table: [in a new window]
Associations between long term use of acid suppressing drugs and risk of oesophageal adenocarcinoma (OA) compared with non-users stratified by |
Relevant Articles
- Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats
- M R Ebrahimkhani, S Kiani, F Oakley, T Kendall, A Shariftabrizi, S M Tavangar, L Moezi, S Payabvash, A Karoon, H Hoseininik, D A Mann, K P Moore, A R Mani, and A R Dehpour
Gut 2006 55: 1606-1616.[Abstract] [Full Text] [PDF]
- Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment
- K Weissenborn, J C Ennen, M Bokemeyer, B Ahl, U Wurster, H Tillmann, C Trebst, H Hecker, and G Berding
Gut 2006 55: 1624-1630.[Abstract] [Full Text] [PDF]
- Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress
- M Zareie, K Johnson-Henry, J Jury, P-C Yang, B-Y Ngan, D M McKay, J D Soderholm, M H Perdue, and P M Sherman
Gut 2006 55: 1553-1560.[Abstract] [Full Text] [PDF]
- Quantitative measurement and visual assessment of ileal Crohns disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein
- J F Colombel, C A Solem, W J Sandborn, F Booya, E V Loftus, Jr, W S Harmsen, A R Zinsmeister, K D Bodily, and J G Fletcher
Gut 2006 55: 1561-1567.[Abstract] [Full Text] [PDF]
- Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK
- L A García Rodríguez, J Lagergren, and M Lindblad
Gut 2006 55: 1538-1544.[Abstract] [Full Text] [PDF]
- Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours
- G B Turner, B T Johnston, D R McCance, A McGinty, R G P Watson, C C Patterson, and J E S Ardill
Gut 2006 55: 1586-1591.[Abstract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
